← Back
Data updated: Mar 10, 2026
EMMAUS MEDCL
Pharmaceuticals
EMMAUS MEDCL is a pharmaceutical company with 2 FDA-approved products.
2004
Since
2
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2004-06-10
- Latest
- 2025-06-18
- Applications
- 2